{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:23:03Z","timestamp":1789665783146,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejphar.2015.01.051","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T13:51:17Z","timestamp":1426168277000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist"],"prefix":"10.1016","volume":"756","author":[{"given":"Dennis","family":"Sprecher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Man","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Boullay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1424-719X","authenticated-orcid":false,"given":"Anne-Charlotte","family":"de Gouville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.01.051_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","article-title":"Influence of nicotinic acid on serum cholesterol in man","volume":"54","author":"Altschul","year":"1955","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2015.01.051_bib2","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR 109A (PUMA-G\/GPR109A) mediates nicotinic acid-induced flushing","volume":"115","author":"Benyo","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2015.01.051_bib3","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid induced flushing is mediated by activation of epidermal Langerrhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0021-9258(18)93503-9","article-title":"Effects of lipolytic and antilipolytic substances on adenosine 3\u2032,5\u2032-monophosphate levels in isolated fat cells","volume":"243","author":"Butcher","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.01.051_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/dom.12132","article-title":"GSK256073, a selective agonist of G-protein-coupled receptor 109A reduces serum glucose in subjects with type 2 diabetes melitus","volume":"15","author":"Dobbins","year":"2013","journal-title":"Diab. Obes. Metab."},{"key":"10.1016\/j.ejphar.2015.01.051_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.48.113006.094746","article-title":"Nicotinic acid: pharmacological effects and mechanism of action","volume":"48","author":"Gille","year":"2008","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib8","doi-asserted-by":"crossref","first-page":"35U","DOI":"10.1016\/S0002-9149(98)00952-7","article-title":"Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study","volume":"82","author":"Goldberg","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib9","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2015.01.051_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"HPS2-THRIVE Collaborative Group","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib11","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.17.10.2020","article-title":"Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport","volume":"17","author":"Jin","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1525-1497.1997.07118.x","article-title":"Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions","volume":"12","author":"Jungnickel","year":"1997","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2012.10.030","article-title":"The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression","volume":"61","author":"Lavigne","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003877","article-title":"Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression","volume":"4","author":"Lauring","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbrc.2005.12.022","article-title":"Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74","volume":"340","author":"Mahboubi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2015.01.051_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2006.05.008","article-title":"The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target","volume":"27","author":"Offermanns","year":"2006","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2015.01.051_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1113\/jphysiol.1967.sp008210","article-title":"The effect of a non-ionic detergent (Triton WR 1339) on the removal of triglyceride fatty acids from the blood of the rat","volume":"190","author":"Otway","year":"1967","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2015.01.051_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1113\/jphysiol.1967.sp008211","article-title":"The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions","volume":"190","author":"Otway","year":"1967","journal-title":"J. Physiol."},{"issue":"13 suppl 2","key":"10.1016\/j.ejphar.2015.01.051_bib19","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/ajhp\/60.suppl_2.S9","article-title":"Overview of niacin formulations: differences in pharmacokinetics, efficacy and safety","volume":"60","author":"Pieper","year":"2003","journal-title":"Am. J. Health. Syst. Pharm."},{"key":"10.1016\/j.ejphar.2015.01.051_bib20","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1074\/jbc.M701866200","article-title":"Nicotinic acid receptor agonists differentially activate downstream effectors","volume":"282","author":"Richman","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.01.051_bib21","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1021\/jm800258p","article-title":"3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice","volume":"51","author":"Semple","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.01.051_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2015.01.051_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/med.20102","article-title":"Nicotinic acid receptor subtypes and their ligands","volume":"27","author":"Soudijn","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2015.01.051_bib24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"The AIM-HIGH Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2015.01.051_bib27","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T03:55:58Z","timestamp":1651463758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":26,"alternative-id":["S0014299915001740"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.051","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}